Elena S. Ratner

Oncology

20 York St
New Haven, CT 06510

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

Preclinical in vitro and in vivo activity of trastuzumab deruxtecan against ERBB2-mutated cervical carcinomas with low HER2 expression.

Preclinical in vitro and in vivo activity of trastuzumab deruxtecan against ERBB2-mutated cervical carcinomas with low HER2 expression.

Journal: Gynecologic oncology reports

Published: June 03, 2026

Preclinical activity of tisotumab vedotin, an antibody-drug conjugate targeting tissue factor, in uterine serous carcinoma.

Preclinical activity of tisotumab vedotin, an antibody-drug conjugate targeting tissue factor, in uterine serous carcinoma.

Journal: Gynecologic oncology

Published: May 29, 2026

Reuse of the same uterine graft: Emerging considerations in allotransplantation.

Reuse of the same uterine graft: Emerging considerations in allotransplantation.

Journal: Transplantation reviews (Orlando, Fla.)

Published: May 26, 2026

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Journal: Gynecologic oncology

Published: March 19, 2026

Integrated mutational landscape analysis of endometrial stromal sarcoma.

Integrated mutational landscape analysis of endometrial stromal sarcoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 27, 2026

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 14, 2026

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 14, 2026

Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts.

Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts.

Journal: Gynecologic oncology

Published: December 02, 2025

Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and p53 Status.

Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and p53 Status.

Journal: Gynecologic oncology reports

Published: November 06, 2025

"Showing some care": interest-holders' perspectives on addressing health-related social conditions in ovarian cancer.

"Showing some care": interest-holders' perspectives on addressing health-related social conditions in ovarian cancer.

Journal: The oncologist

Published: October 04, 2025

HIPEC with cisplatin desensitization at the time of secondary debulking in a patient with a prior carboplatin hypersensitivity reaction.

HIPEC with cisplatin desensitization at the time of secondary debulking in a patient with a prior carboplatin hypersensitivity reaction.

Journal: Gynecologic oncology reports

Published: September 26, 2025

Addressing dermatologic toxicities in gynecologic cancer: development and evaluation of a patient education pamphlet.

Addressing dermatologic toxicities in gynecologic cancer: development and evaluation of a patient education pamphlet.

Journal: International journal of women's dermatology

Published: August 25, 2025

Showing 1-12 of 171

Last Updated: 09/26/2026